10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-091459`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	cldx-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 63 Cash Flow Statement 62

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$138.89M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$53.15M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.01M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$329.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.75M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.30M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	16.97M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.09M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$208.99M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$66.70M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	16.97M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$4.03M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.09M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$4.04M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.47M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.13M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$45.19M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Total Assets	`Assets`	$261.40M	USD	Point-in-time
Total Assets	`Assets`	$122.93M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$950.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.17M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.47M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.32M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.94M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.03M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.10M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.64M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$10.84M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.71M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.72M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$10.40M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$15.55M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.91M	USD	Point-in-time
Total Liabilities	`Liabilities`	$22.96M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 39,093,868 and 16,972,077 Shares Issued and Outstanding at June 30, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$39.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 39,093,868 and 16,972,077 Shares Issued and Outstanding at June 30, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.10B	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.27B	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.62M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.04B	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$112.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$94.03M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$238.44M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$83.70M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$109.63M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$124.06M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$261.40M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$122.93M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$715.00K	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.96M	USD	2 Qtrs
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.14M	USD	2 Qtrs
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$236.00K	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$21.23M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$21.40M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$9.71M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$10.08M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$8.80M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.53M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$7.19M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.91M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	2 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-502.00K	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$5.13M	USD	1 Quarter
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.90M	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.02M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$27.20M	USD	2 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$12.97M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$32.34M	USD	2 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$11.60M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-24.23M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-12.26M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-11.37M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-30.20M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$347.00K	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.18M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$478.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$106.00K	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.26M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.88M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.02M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.78M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-23.66M	USD	2 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.03M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.78M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-29.02M	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-2.21	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.84	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.95M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.74M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	22.08M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.13M	shares	2 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-23.66M	USD	2 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.03M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.78M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-29.02M	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-25.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-22.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$55.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$19.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-23.68M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.74M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.03M	USD	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.78M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.02M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.66M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.03M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.50M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.31M	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$335.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$652.00K	USD	2 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.00K	USD	2 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$20.00K	USD	2 Qtrs
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	2 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-502.00K	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$5.13M	USD	1 Quarter
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.90M	USD	2 Qtrs
(Gain) Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.02M	USD	1 Quarter
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	2 Qtrs
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$3.16M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.41M	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-686.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.99M	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$137.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$436.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-254.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.60M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.41M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.83M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-24.27M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.33M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.39M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$47.00M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$58.56M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$132.44M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.15M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$484.00K	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$20.00K	USD	2 Qtrs
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$8.34M	USD	2 Qtrs
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-86.56M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$166.67M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$11.36M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$24.00K	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$9.00K	USD	2 Qtrs
Issuance of Term Loan	`ProceedsFromIssuanceOfDebt`	$2.96M	USD	2 Qtrs
Payment of Term Loan	`RepaymentsOfDebt`	$2.96M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$11.37M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$166.69M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$56.80M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.57M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$22.00K	USD	2 Qtrs
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$55.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.